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Extended abstract 21 
 22 
Study question: Does starting intrauterine insemination with ovarian stimulation (IUI-OS) 23 
within one and a half years after completion of the fertility workup increase ongoing 24 
pregnancy rates compared to expectant management in couples with unexplained 25 
subfertility? 26 
 27 
Summary answer: IUI-OS is associated with higher chances of ongoing pregnancy 28 
compared to expectant management in unexplained subfertile couples, specifically those 29 
with poor prognoses of natural conception i.e. <15% over 6 months or <25% over one year. 30 
 31 
What is known already: IUI-OS is often the first-line treatment for couples with unexplained 32 
subfertility. Two randomised controlled trials compared IUI-OS to expectant management 33 
using different thresholds for the prognosis of natural conception as inclusion criteria and 34 
found conflicting results. A cohort of couples with unexplained subfertility exposed to 35 
expectant management and IUI-OS offers an opportunity to determine the chances of 36 
conception after both strategies and to evaluate whether the effect of IUI-OS depends on a 37 
couple’s prognosis of natural conception. 38 
 39 
Study design, size, duration: A prospective cohort study on couples with unexplained or 40 
mild male subfertility who could start IUI-OS at any point after completion of the fertility 41 
workup, recruited in 7 Dutch centres between January 2002 and February 2004. Decisions 42 
regarding treatment were subject to local protocols, the judgement of the clinician and the 43 
wishes of the couple. Couples with bilateral tubal occlusion, anovulation, or a total motile 44 
sperm count <1x106 were excluded. Follow up was censored at the start of IVF, after the last 45 
IUI cycle or at last contact and truncated at a maximum of one and a half years after the 46 
fertility workup. 47 
 48 
Participants/materials, setting, methods: The endpoint was time to conception leading to 49 
an ongoing pregnancy. We used the sequential Cox approach comparing in each month 50 
ongoing pregnancy rates over the next 6 months of couples who started IUI-OS to couples 51 
who did not. We calculated the prognosis of natural conception for individual couples, 52 
updated this over consecutive failed cycles and evaluated whether prognosis modified the 53 
effect of starting IUI-OS. We corrected for known predictors of conception using inverse 54 
probability weighting. 55 
 56 
Main results and the role of chance: Data from 1896 couples were available. There were 57 
800 couples whom had at least one IUI-OS cycle within one and a half years post fertility 58 
workup of whom 142 couples conceived (rate: 0.50 per couple per year, median follow up 4 59 
months). The median period between fertility workup completion and starting IUI-OS was 6.5 60 
months. Out of 1096 untreated couples, 386 conceived naturally (rate: 0.31 per couple per 61 
year, median follow up 7 months). 62 
Starting IUI-OS was associated with a higher chance of ongoing pregnancy by a pooled, 63 
overall hazard ratio of 1.96 (95%CI: 1.47-2.62) compared to expectant management. The 64 
effect of treatment was modified by a couple’s prognosis of achieving natural conception 65 
(p=0.01), with poorer prognoses or additional failed natural cycles being associated with a 66 
stronger effect of treatment. The predicted 6-month ongoing pregnancy rate for a couple with 67 
a prognosis of 25% at completion of the fertility workup over the next 6 cycles (approximately 68 
40% over one year) was 25% (95%CI: 21-28%) for expectant management and 24% 69 
(95%CI: 9-36%) when starting IUI-OS directly. For a couple with a prognosis of 15% (25% 70 
over one year), these predicted rates were 17% (95%CI: 15-19%) for expectant management 71 
and 24% (95%CI: 15-32%) for starting IUI-OS. 72 
 73 
Limitations, reasons for caution: The effect estimates are based on a prospective cohort 74 
followed up for one and a half years after completion of the fertility workup. Although we 75 
balanced the known predictors of conception between treated and untreated couples using 76 
inverse probability weighting, observational data may be subject to residual confounding. The 77 
results need to be confirmed in external datasets. 78 
 79 
Wider implications of the findings: These results explain the discrepancies between 80 
previous trials that compared IUI-OS to expectant management, but further studies are 81 
required to establish the threshold at which IUI-OS is (cost-)effective. 82 
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Introduction 93 
Couples who have been trying to conceive for at least 12 months and whose fertility workup 94 
fails to reveal any abnormalities are considered to have unexplained subfertility (Aboulghar et 95 
al., 2009; Brandes et al., 2010). IUI is often used as first-line treatment in these couples, 96 
especially in combination with ovarian stimulation (OS), since it is less invasive and less 97 
costly than IVF (Tjon-Kon-Fat et al., 2015), despite conflicting evidence from randomised 98 
controlled trials regarding the effectiveness of IUI-OS. The two trials that compared IUI-OS to 99 
expectant management used different thresholds for the prognosis of natural conception as 100 
inclusion criteria. In women with an intermediate prognosis to conceive naturally i.e. an 101 
estimated probability between 30% and 40% to conceive within 12 months leading to live 102 
birth, IUI-OS was not more effective than expectant management (Steures et al., 2006). In 103 
women with a poor prognosis i.e. <30% over 12 months, IUI-OS resulted in more live births 104 
than expectant management (Farquhar et al., 2018). 105 
The results of these two trials suggest that IUI-OS might be effective in couples with a 106 
poor prognosis, whereas it might be ineffective in couples with better prognoses. For 107 
example, couples who have been trying to conceive for a longer period of time and where the 108 
female partner is older and/or nulliparous might derive greater benefit from treatment 109 
(McLernon et al., 2014). However, these two trial results cannot be taken as definite 110 
evidence that we should treat all couples with a poor prognosis of natural conception. Other -111 
unmeasured- differences between the two trials could also explain the different results. The 112 
hypothesis that the prognostic profile of a couple determines the benefit of IUI-OS thus 113 
needs to be addressed directly in a single population that is heterogeneous in terms of their 114 
prognosis of natural conception. Knowledge on who is more likely to conceive with IUI-OS is 115 
critical in informing clinical decision making and avoids unnecessary treatment in some while 116 
ensuring early and appropriate access to active treatment in others. 117 
The aim of this study was to determine the chances of conception after expectant 118 
management or starting IUI-OS in a cohort of unexplained subfertile couples that included 119 
couples who followed both strategies. 120 
 121 
 122 
Materials and Methods 123 
 124 
Patient selection 125 
Couples were selected from a prospective cohort recruited across 38 hospitals in The 126 
Netherlands between January 2002 and February 2004, the detailed protocol for which has 127 
been described elsewhere (van der Steeg et al., 2007). The purpose of recruiting this cohort 128 
was to validate the Hunault model to predict the chances of natural conception leading to live 129 
birth (Hunault et al., 2004). In 7 of these 38 centres, data on IUI cycles was also recorded 130 
and used to validate a prediction model for chances of ongoing pregnancy per IUI cycle 131 
(Steures et al., 2004; Custers et al., 2007). IVF pregnancy outcome data were not routinely 132 
collected but starting dates of IVF treatment were known. Couples from the 7 centres that 133 
recorded IUI data were included in the current study. 134 
We defined subfertility as couples trying to conceive for at least 12 months (Habbema et al., 135 
2004; Gnoth et al., 2005). Selected subfertile couples had regular menstrual cycles (cycle 136 
length between 23 and 35 days), at least one patent fallopian tube if hysterosalpingography, 137 
laparoscopy or transvaginal hydrolaparoscopy was performed and a total motile sperm count 138 
> 1 x 106. 139 
Women were evaluated for tubal patency according to the Dutch national guidelines and 140 
protocols from 2002 to 2004 recommending the chlamydia antibody test (CAT) as the first-141 
line test (NVOG, 2004). In women who were CAT negative, invasive diagnostic testing was 142 
usually refrained from, thus limiting tubal patency testing to the CAT (Broeze et al., 2011). 143 
Women who tested positive on the CAT, or if their history indicated a high risk of tubal 144 
pathology, were subsequently tested with hysterosalpingography, transvaginal 145 
hydrolaparoscopy or laparoscopy. 146 
Decisions regarding treatment - IUI, IVF or expectant management - were made according to 147 
local protocols and subject to the judgement of the clinician and the wishes of the couple. 148 
Expectant management was defined as no intervention or monitoring aside from the advice 149 
to have intercourse. Eighty-three percent of couples who received IUI used stimulation in at 150 
least one cycle and treatment was considered IUI-OS. The IUI protocols have been 151 
described in more detail elsewhere (Custers et al., 2007). 152 
 153 
Follow up and outcome definitions 154 
For the follow up of selected couples, we distinguished between time spent pursuing 155 
expectant management and time spent receiving IUI-OS cycles. The start of the IUI period 156 
was defined as the first day of menstruation before the first IUI cycle. The end of the IUI 157 
period was defined as the first day of menstruation before the last IUI cycle. With this 158 
definition, and because natural conceptions after unsuccessful IUI cycles were not recorded, 159 
all pregnancies in the IUI period resulted from IUI. The start of expectant management 160 
coincided with the completion of the fertility workup and ended at the last date of contact, first 161 
day of last menstruation before starting IUI or IVF or, in case they conceived naturally, the 162 
first day of the last menstruation before conceiving. We visualised the transition from 163 
expectant management to IUI-OS in the cohort by counting the number of couples in both 164 
groups over follow up. 165 
The endpoint was ongoing pregnancy, defined as the presence of foetal cardiac activity at 166 
transvaginal sonography at a gestational age of at least 12 weeks (van der Steeg et al., 167 
2007). Couples who miscarried before 12 weeks were not censored since they could still 168 
achieve ongoing pregnancy in subsequent cycles after their miscarriage. If no ongoing 169 
pregnancy occurred, we censored follow up at the end of expectant management or, if 170 
treated, at the end of the IUI period. 171 
 172 
Cumulative pregnancy rates over multiple IUI cycles 173 
We opted for the Sequential Cox approach to be able to compare treated and untreated 174 
couples over multiple cycles after starting treatment, not only directly after completion of the 175 
fertility workup but also if they started later (Gran et al., 2010). 176 
In this approach, we derived multiple datasets from the cohort in which couples started IUI-177 
OS at approximately the same point in time and compared them to couples undergoing 178 
expectant management at that time, mimicking hypothetical randomised controlled trials 179 
(Gran et al., 2010). At completion of the fertility workup and each consecutive month 180 
thereafter, i.e. the landmark time points, we constructed such a new mimicked trial from our 181 
data in which we included all couples who remained in the cohort i.e. couples who had not 182 
conceived and who were not lost to follow up before that point. In these ‘trial’ sets spanning 6 183 
months, we considered couples as treated if they started IUI-OS early i.e. within one month 184 
after the landmark time point. Couples who started IUI-OS within the 6 month window of a 185 
trial, but later than one month after the landmark time point, were ‘artificially censored’ at the 186 
time of starting IUI-OS to retain a treatment group that all started at approximately the same 187 
time. This way, couples were not included in a single group throughout the study. Instead, 188 
couples who started IUI-OS were analysed as controls (under expectant management) in the 189 
trials preceding the month in which they started IUI-OS, at which point they were analysed 190 
over cumulative treatment cycles as part of the treated (IUI-OS) group in the mimicked trial 191 
that started that month. 192 
The maximum follow up period of 18 months after the fertility workup was chosen because of 193 
the small numbers of couples starting treatment thereafter. Thus, we derived trial datasets from 194 
landmark time point 0 i.e. the fertility workup until the final landmark time point at 12 months 195 
after the workup, sliding forward in intervals of one month, resulting in a total of 13 mimicked 196 
trials. 197 
 198 
Adjusting for patient characteristics that differed between treated and untreated couples 199 
To balance treated, untreated, artificially censored and uncensored couples in important 200 
predictors of conception, we applied iterative inverse probability weighting (Austin, 2011; van 201 
der Wal, 2011; Austin and Stuart, 2015). Details on how we derived the weights to adjust for 202 
these differences are given in the Supplementary Material. The patient characteristics we 203 
chose to balance were: female age, duration of subfertility, primary or secondary subfertility, 204 
total motile sperm count, referral status, presence of one-sided tubal pathology and fertility 205 
clinic (Hunault et al., 2004; van Eekelen et al., 2017a). We calculated the mean weight, which 206 
is ideally around 1 to avoid inflating the effective sample size (Cole and Hernan, 2008). 207 
 208 
We assessed the degree of balance in patient characteristics before and after weighting using 209 
the standardized mean difference between the treated and untreated group. A lower 210 
standardized mean difference between groups represents better balance and a value below 211 
0.10 generally indicates no important difference (Austin, 2011; Austin and Stuart, 2015). 212 
 213 
Statistical analysis 214 
We analysed the weighted datasets using a pooled Cox proportional hazards model with IUI-215 
OS or expectant management as a treatment covariate. We calculated an overall hazard ratio 216 
by stratifying on all 13 mimicked trials. We used a robust sandwich variance estimator to adjust 217 
precision measures since couples can be included in multiple trials (Wei et al., 1989). Using 218 
the pooled Cox model, we predicted the probability of conception over 6 months when couples 219 
start IUI-OS immediately after completion of the fertility workup or when they remain on 220 
expectant management. 221 
 222 
Modification of the estimated effect of IUI-OS by the prognosis of natural conception 223 
To address whether the effect of starting IUI-OS depends on the decreasing prognosis of 224 
natural conception of the individual couple, we added a treatment-by-prognosis interaction 225 
term to the model. We calculated a time-updated prognosis of natural conception over the next 226 
6 cycles at the start of each mimicked trial dataset by using the dynamic prediction model that 227 
comprises female age, duration of subfertility, primary or secondary subfertility, percentage of 228 
progressive motile sperm and referral by a general practitioner or specialist (van Eekelen et 229 
al., 2017a). The prognosis for a couple is thus not one fixed value throughout the study, but 230 
decreases after consecutive failed natural cycles. We included the complementary log-log of 231 
this updated prognosis as a main effect, the main effect for treatment and the treatment-by-232 
prognosis interaction effect in the pooled Cox model. The weighting procedure was adjusted 233 
slightly for this analysis (VanderWeele, 2009) because the difference in prognosis between 234 
groups was adjusted for by adding it to the model as a main effect (see also Supplementary 235 
Material). 236 
For three hypothetical couples, we visually depicted the relationship between their 237 
worsening prognoses and the accompanying 6-month cumulative predicted probability of 238 
conception following expectant management or starting IUI-OS, shown as treatment is initiated 239 
later. The first example is a couple referred by their general practitioner, where the female 240 
partner is nulliparous and 32 years old, the couple has 1 year of subfertility at the time of 241 
completion of the fertility workup and the semen analysis showed 37% progressively motile 242 
sperm. In this case, the estimated prognosis of natural conception over the next 6 cycles is 243 
25%. A second couple with the same characteristics except for a 2 year duration of subfertility 244 
at the completion of the fertility workup has a prognosis of 20% while a third couple with the 245 
same characteristics but for a 3.5 year duration of subfertility has a prognosis of 15%. At the 246 
time of the completion of their fertility workup, these couples have prognoses of 25%, 20% and 247 
15% respectively over 6 cycles, which translates to approximately 40%, 32% and 25% 248 
respectively over 13 cycles i.e. one year (van Eekelen et al., 2017a). 249 
If these three hypothetical couples should fail to conceive naturally over the course of one year 250 
after completion of the fertility workup i.e. if they would ‘enter’ the latest mimicked trial, their 251 
prognoses over the next 6 cycles decrease to 13%, 10% and 7% respectively. 252 
Estimated cumulative probabilities of ongoing pregnancy from this model are derived from the 253 
separate mimicked trials that all have different observed conception rates, thus predictions 254 
may fluctuate. We considered an absolute difference of more than 5% between point estimates 255 
of the cumulative ongoing pregnancy rates, estimated at the completion of the fertility workup, 256 
to signify a benefit of IUI-OS. 257 
 258 
In addition to the impact of prognosis or a failure to conceive in consecutive natural cycles on 259 
the effect of treatment, we modelled if the effect of IUI-OS depends on the time of initiation of 260 
treatment by adding an additional interaction between treatment and landmark time point to 261 
the pooled Cox model already including treatment, prognosis and the treatment-by-prognosis 262 
interaction. We also added a three-way interaction between treatment, prognosis and 263 
landmark time point to the previous model to see if the effect modification of prognosis on IUI-264 
OS changed over mimicked trials i.e. when starting treatment later. 265 
As a sensitivity analysis, we tested whether couples with mild male subfertility had more or 266 
less benefit from IUI-OS compared to couples that did not have mild male subfertility. We 267 
classified couples as having mild male subfertility when they had a total motile count between 268 
1 and 10x106, then tested the hypothesis by fitting a Cox model including treatment, the mild 269 
male subfertility classification and their interaction. 270 
 271 
We used Akaike’s Information Criterion (AIC) and Wald tests for the interaction terms to 272 
determine whether including the interactions resulted in a better fit of the model to the data 273 
(Akaike, 1974). 274 
  275 
Missing data 276 
Missing data were accounted for using multiple imputation in a previous study, creating ten 277 
imputation sets (van Eekelen et al., 2017a). In total, only 1.3% of patient characteristic data 278 
used for this study were missing and we chose to use one randomly selected imputation set 279 
for our analyses. 280 
 281 
All statistical analyses were performed using R version 3.3.2 2222(R Core Team (2013). R: A 282 
language and environment for statistical computing. R Foundation for Statistical Computing, 283 
Vienna, Austria. http://www.R-project.org/) using the survival, dynpred and CreateTableOne 284 
packages. 285 
 286 
 287 
Results 288 
From the 7860 couples included in the initial cohort, we selected 1896 couples for analysis 289 
(Figure 1) (van der Steeg et al., 2007). 290 
Of these, 800 couples had at least one IUI cycle within one and a half years after the workup 291 
for a total of 3119 cycles (Table I) following which 142 couples conceived leading to ongoing 292 
pregnancy (rate: 0.50 per couple per year over a median follow up for IUI of 4 months).  Out 293 
of 1096 untreated couples followed up for one and a half years after the fertility workup, 386  294 
conceived naturally leading to ongoing pregnancy (rate: 0.31 per couple per year over a 295 
median follow up of 7 months). Among women who remained on expectant management, 68 296 
miscarried and 7 had an ectopic pregnancy. Among women treated with IUI-OS, 35 297 
miscarried and 7 women had an ectopic pregnancy. 298 
Out of 800 couples who underwent IUI-OS, 64 started treatment directly after completion of 299 
the fertility workup and 736 had a prior period of expectant management after completion of 300 
their fertility workup. The median period between completion of the fertility workup and 301 
starting IUI-OS was 6.5 months. In 57% of IUI cycles, recombinant gonadotrophins were 302 
used, in 24% no medication was used, in 9% clomiphene citrate was used and in 7% urinary 303 
gonadotrophins were used. In 3% of cycles, another type of drug was used or data were 304 
missing. Two hundred and sixty eight couples (14%) received IVF as their first treatment, 305 
with a median period of expectant management of one year between completion of the 306 
fertility workup and the start of IVF. 307 
We depicted the number of couples currently in the expectant management or IUI-OS group 308 
over time in Figure 2. Until ten months after the fertility workup, there was a steady increase 309 
in the number of couples who were currently in a treatment pathway, after which this number 310 
declined again. 311 
 312 
The baseline characteristics for couples who eventually received at least one cycle of IUI-OS 313 
within one and a half years after the fertility workup or who remained untreated are 314 
summarized in Table I. Treated couples more often had primary subfertility (70% versus 315 
60%) and were more often tested for tubal patency using laparoscopy, 316 
hysterosalpingography or transvaginal hydrolaparoscopy (55% versus 39%) compared to 317 
couples that were not treated. Female age, on average 32.1 years old (SD: 4.4) and median 318 
duration of subfertility of 1.6 years (5th-95th percentile: 1.0-4.7), both at completion of the 319 
fertility workup, were similar between groups. 320 
In the weighted trial datasets, the standardized mean differences between treated and 321 
untreated couples were below 0.10 for all characteristics, indicating that the two groups were 322 
well balanced in terms of prognostic factors after weighting. The mean weight used in the 323 
pooled dataset was 1.00, indicating that weights are stable and do not artificially inflate 324 
sample size. 325 
 326 
Effect estimates of IUI-OS 327 
Starting IUI-OS was associated with increased ongoing pregnancy rates compared to 328 
expectant management as shown by an estimated hazard ratio of 1.96 (95%CI: 1.47-2.62), 329 
pooling all 13 mimicked, weighted trials running over 6 months. 330 
The predicted probability that a couple would conceive over the course of 6 months of 331 
expectant management after the fertility workup was 17% (95%CI: 16-19%). If the couple 332 
started IUI-OS directly after completion of the fertility workup, their estimated probability of 333 
conception was 31% (23-38%) over that same period. 334 
 335 
The relative effect of IUI-OS depended on the prognosis of natural conception (p=0.01). 336 
The relationship between prognosis and the estimated treatment effect as time progresses is 337 
visualised in Figure 3, in which estimated 6-month cumulative probabilities of conception 338 
with and without starting IUI-OS are shown for three different example couples with a 339 
prognosis to conceive naturally at completion of the fertility workup over the next 6 cycles of 340 
25% (A), 20% (B) or 15% (C), which were updated over time when these couples fail 341 
consecutive natural cycles and start treatment later. 342 
The absolute cumulative predicted probability to conceive over 6 months after starting IUI-OS 343 
was stable at around 24%, regardless of the prognosis at completion of the workup or the 344 
time thereafter when a couple would start, which leads to larger differences between IUI-OS 345 
and expectant management for couples at lower prognoses of natural conception and/or for 346 
couples after additional failed natural cycles, both on absolute and relative scale. 347 
It follows from Figure 3 that a couple who has tried to conceive for 3.5 years post fertility 348 
work up with a prognosis of 15% over the next 6 months (approximately 25% over one year) 349 
has a higher predicted probability when starting treatment directly after completion of the 350 
fertility workup compared to expectant management, whereas a couple who tried to conceive 351 
for 1 year with a prognosis of 25% (approximately 40% over one year) does not. 352 
 353 
Apart from the influence of decreasing prognosis over time, we found no evidence that the 354 
relative effect of IUI-OS changed as treatment was started later (p=0.38) nor that the 355 
dependency of the relative effect of IUI-OS on prognosis additionally depended on when 356 
treatment was started (p=0.66). We found no evidence for a difference in the benefit of IUI-357 
OS between couples with or without mild male subfertility (p=0.75). 358 
 359 
 360 
Discussion 361 
In couples with unexplained subfertility, starting IUI-OS within one and a half years after 362 
completion of the fertility workup was associated with increased ongoing pregnancy rates 363 
over 6 months compared to expectant management. The estimated benefit of treatment 364 
depended on the prognosis of natural conception, not only expressed at the time of 365 
completion of the fertility workup but also after additional failed natural cycles. 366 
 367 
Our study has a number of strengths. First, the chosen study design represents the best 368 
possible design for an observational study, being less subject to selection bias than a 369 
comparison of separate cohorts since unexplained subfertile couples that will eventually be 370 
treated or not were both sampled using a prospective approach and followed up thereafter 371 
(Aboulghar et al., 2009; McLernon et al., 2014; van Eekelen et al., 2017b). In addition, we 372 
were able to adjust for differences in prognostic factors between treated and untreated 373 
couples and the relatively large sample size and long follow up meant we were able to study 374 
whether the prognosis of natural conception influences the effect of IUI, an approach aimed 375 
to improve the management of unexplained subfertile couples and to explain the 376 
discrepancies between existing trials. 377 
Second, data collection took place before the current Dutch clinical guideline for 378 
fertility recommending the application of the prediction model for natural conception leading 379 
to live birth by Hunault et al. to decide on treatment (NVOG, 2010). Because decisions 380 
regarding treatment were not clear-cut at the time, this led to considerable variation in 381 
observed time points when couples started IUI and ensured that most couples would be 382 
eligible for treatment, reducing confounding by indication. 383 
Third, we defined the IUI period as the time between the first and last cycle, even 384 
when treatment cycles were not consecutive, which is a realistic measure of the actual time 385 
that couples spend in an IUI program. This allowed comparison with expectant management 386 
on the same axis representing ‘real’ calendar time and allows our results to be easily 387 
interpreted (Daya, 2005). 388 
Fourth, we focused on the clinical question on what would occur when treatment 389 
would be started at a given time point and applied methodology that matched this question. 390 
When analysing the data using a regular Cox approach with a time-varying covariate for 391 
treatment, the couples currently undergoing IUI at a certain point in time consist of couples 392 
who just started and couples who already failed several cycles, such that the resulting 393 
estimate would be different from ‘starting IUI’ and more difficult to interpret (Gran et al., 394 
2010). 395 
 396 
Our study also has some limitations. An adequately powered, randomised controlled trial 397 
offers the best way of evaluating the effectiveness of IUI-OS compared to expectant 398 
management; our observational study following a cohort of couples after both strategies is a 399 
less robust design because treatment was not randomly allocated, which means that treated 400 
and untreated couples might differ on important factors related to conception. We tried to 401 
balance these factors in both groups using (iterative) inverse probability weighting. 402 
Nevertheless, our results could still be influenced by unmeasured factors related to 403 
conception i.e. residual confounding. However, the advantage of using observational data on 404 
couples with a wide range of prognoses of natural conception was that we could directly 405 
address the hypothesis regarding the influence of prognosis on the relative effect of IUI-OS. 406 
Addressing this hypothesis with an experimental design would require the unfeasible, 407 
inefficient and indirect approach of conducting multiple smaller, separate trials applying 408 
different inclusion criteria. 409 
The primary outcome was ongoing pregnancy since following couples for live birth 410 
increases logistical efforts that the study budget did not allow for. In addition, following 411 
couples for live birth increases the likelihood of loss-to-follow-up. Ongoing pregnancy is 412 
generally considered an appropriate and efficient proxy for live birth in clinical research: 413 
approximately 95% of ongoing pregnancies lead to live birth (Clarke et al., 2010; Braakhekke 414 
et al., 2014). 415 
54% of couples only received a CAT and not a visual test for tubal patency. It is 416 
unlikely that this has led to clinically relevant differences in tubal pathology between treated 417 
and untreated couples because the decision to initiate IUI-OS was taken in the absence of 418 
visual confirmation of tubal patency and thus, any difference is likely due to chance. 419 
We lacked the sample size to accurately estimate interactions between all separate 420 
patient characteristics female age, duration of subfertility etc. and IUI-OS to further 421 
individualize treatment effects. Instead, we opted for the summary score in terms of an 422 
estimated prognosis such that only one additional parameter was required (Dahabreh et al., 423 
2016) and updated this over time using our previously developed dynamic model for natural 424 
conception to determine when a couple would benefit from starting treatment (van Eekelen et 425 
al., 2017a).  426 
 427 
Our findings add context to the apparent discrepancies between the two randomised 428 
controlled trials that compared IUI-OS to expectant management (Steures et al., 2006; 429 
Farquhar et al., 2018). Steures et al. included 253 couples with an intermediate prognosis for 430 
natural conception i.e. 30% to 40% as calculated by the Hunault model and found a risk ratio 431 
of 0.85 (95%CI: 0.63-1.10) for ongoing pregnancy after IUI-OS compared to expectant 432 
management over the course of 6 months. The pragmatic TUI trial by Farquhar et al. 433 
included 201 couples with a prognosis <30% and found a beneficial effect of IUI-OS 434 
compared to expectant management by a risk ratio of 3.41 (95%CI: 1.71-6.79). Couples in 435 
the latter study had a much worse prognosis of natural conception compared to the first; 436 
mostly due to an average duration of subfertility of 3.6 years that was almost double the 437 
average duration in the trial by Steures et al. and in the present study. Our finding that the 438 
benefit of IUI-OS is larger in couples with poorer prognoses of natural conception, both on 439 
relative and absolute scale, may primarily explain and support the difference in results. 440 
 441 
Couples with a prognosis of natural conception of 25% over 6 months (approximately 40% 442 
over one year) or higher were not expected to benefit from IUI-OS. For couples with a 443 
prognosis around 20% over 6 months (approximately 32% over one year), it was uncertain if 444 
we can expect a clinically relevant benefit of IUI-OS. Couples with a prognosis of 15% over 6 445 
months (approximately 25% over one year) or lower were expected to benefit from IUI-OS as 446 
the absolute difference in pregnancy rates was more than 5%. 447 
Since IUI-OS is invasive, expensive and associated with potential disadvantages such as 448 
ovarian hyperstimulation or multiple pregnancies (Rooney and Domar, 2016), we believe that 449 
counselling couples should involve a discussion about their prognosis when following 450 
alternative treatment scenarios so that they are able to make an informed choice. These 451 
results, in combination with the prognosis of natural conception derived from a prediction 452 
model (van Eekelen et al., 2017a), can be used to attain that goal. 453 
Because confidence intervals around the predicted pregnancy rates after IUI-OS for a given 454 
prognosis were broad in the current study, the results need to be interpreted with caution and 455 
replicated in further research. 456 
 457 
Conclusion 458 
Within one and a half years post fertility workup, starting IUI-OS is associated with higher 459 
chances of conception in couples with unexplained subfertility and a poor prognosis for 460 
natural conception i.e. <15% over 6 months or <25% over one year. Our results explain the 461 
discrepancies between two trials that compared IUI-OS to expectant management using 462 
different inclusion criteria for the prognosis of natural conception. These results may be used 463 
in counselling couples with unexplained subfertility. Future studies should focus on 464 
establishing the threshold for the prognosis of natural conception at which IUI-OS is deemed 465 
(cost-)effective.  466 
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Figure legends 607 
 608 
Figure 1 Flow chart of couples from the cohort who were included in the analysis. 609 
 610 
Figure 2 Number of couples currently on treatment or not as time progresses, depicted in the 611 
original dataset (n=1896) before the sequential Cox procedure. 612 
 613 
Figure 3 The association between the predicted prognosis of natural conception and the 614 
estimated benefit of starting IUI-OS. This is shown as cumulative probabilities over 6 months 615 
(y-axis) when starting IUI-OS or not at different time points after completion of the fertility 616 
workup (x-axis) for three example couples that have three different prognoses at the workup 617 
completion: 25% (panel A), 20% (panel B) or 15% (panel C). The prognosis was calculated 618 
over 6 cycles and updated after additional failed natural cycles. Grey bands represent 95% 619 
confidence limits. 620 
